Quadrivalent influenza modRNA vaccine
C4781004
Phase 3 mab completed
Quick answer
Quadrivalent influenza modRNA vaccine for Influenza, Human is a Phase 3 program (mab) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Influenza, Human
- Phase
- Phase 3
- Modality
- mab
- Status
- completed